Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deal Watch: Roche Aborts But Regeneron, Amgen and Pfizer Sign Up

Executive Summary

Deal activity over the past seven days sees Roche knock back Inovio a second time, Regeneron plan for its future via an alliance with Adicet Bio, Amgen supplement its preclinical pipeline with a candidate from Advaxis, and Pfizer shore up its gene therapy ambitions with an acquisition.

Advertisement

Related Content

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite
Astellas Dips Into Digital Health Via New Venture
Filings Soon As Biogen Snaps Up Ionis' Antisense Treatment
Teva Embarks On New Phase With FTC Clearance Of Allergan Generics
Mayne Cements Place On US Generics Map
Kite Founder Jakobovits Raises $51m For Off-The-Shelf Startup Adicet; Aprecia Prints $35m
Cellectis Success With Off-The-Shelf CAR-T Threatens Kite, Juno, Novartis
Advaxis Sinks On Delayed Disclosure Of Clinical Hold
Inovio surprised by Roche returning prostate cancer immunotherapy
Roche licenses two of Inovio's early-stage DNA vaccines

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel